Literature DB >> 27447168

The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Charles W Drescher1, J David Beatty1,2, Robert Resta2,3, M Robyn Andersen1, Kate Watabayashi1, Jason Thorpe1, Sarah Hawley1, Hannah Purkey1, Jessica Chubak4,5, Nancy Hanson2,3, Diana S M Buist4,5,6, Nicole Urban1,6.   

Abstract

BACKGROUND: Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer. The authors evaluated the effect of referral to genetic counseling on genetic testing and prophylactic oophorectomy in a randomized controlled trial.
METHODS: Data from an electronic mammography reporting system identified 12,919 women with a pedigree that included breast cancer, of whom 625 were identified who had a high risk for inherited susceptibility to ovarian cancer using a risk-assessment questionnaire. Of these, 458 women provided informed consent and were randomized 1:1 to intervention consisting of a genetic counseling referral (n = 228) or standard clinical care (n = 230).
RESULTS: Participants were predominantly aged 45 to 65 years, and 30% and 20% reported a personal history of breast cancer or a family history of ovarian cancer, respectively. Eighty-five percent of women in the intervention group participated in a genetic counseling session. Genetic testing was reported by 74 (33%) and 20 (9%) women in the intervention and control arms (P < .005), respectively. Five women in the intervention arm and 2 in the control arm were identified as germline mutation carriers. Ten women in the intervention arm and 3 in the control arm underwent prophylactic bilateral salpingo-oophorectomy (P < .05).
CONCLUSIONS: Routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery. The findings from the current randomized controlled trial demonstrate the value of implementing strategies that target women at high risk for ovarian cancer to ensure they are offered access to recommended care. CA Cancer J Clin 2016.
© 2016 American Cancer Society, Inc. Cancer 2016;122:3509-3518. © 2016 American Cancer Society. © 2016 American Cancer Society.

Entities:  

Keywords:  genetic counseling; genetic testing; ovarian cancer; referral and consultation; risk assessment; surgical prevention

Year:  2016        PMID: 27447168      PMCID: PMC5253334          DOI: 10.1002/cncr.30190

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.

Authors:  Tom Walsh; Silvia Casadei; Ming K Lee; Christopher C Pennil; Alex S Nord; Anne M Thornton; Wendy Roeb; Kathy J Agnew; Sunday M Stray; Anneka Wickramanayake; Barbara Norquist; Kathryn P Pennington; Rochelle L Garcia; Mary-Claire King; Elizabeth M Swisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

2.  Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.

Authors:  Mary S Beattie; Beth Crawford; Feng Lin; Eric Vittinghoff; John Ziegler
Journal:  Genet Test Mol Biomarkers       Date:  2009-02

Review 3.  Predictors of genetic testing decisions: a systematic review and critique of the literature.

Authors:  Kate Sweeny; Arezou Ghane; Angela M Legg; Ho Phi Huynh; Sara E Andrews
Journal:  J Genet Couns       Date:  2014-04-11       Impact factor: 2.537

4.  Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

Authors:  Noah D Kauff; Nandita Mitra; Mark E Robson; Karen E Hurley; Shaokun Chuai; Deborah Goldfrank; Eve Wadsworth; Johanna Lee; Tessa Cigler; Patrick I Borgen; Larry Norton; Richard R Barakat; Kenneth Offit
Journal:  J Natl Cancer Inst       Date:  2005-09-21       Impact factor: 13.506

5.  Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.

Authors:  Maria C Katapodi; Laurel L Northouse; Kara J Milliron; Guipeng Liu; Sofia D Merajver
Journal:  Psychooncology       Date:  2012-07-24       Impact factor: 3.894

6.  Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.

Authors:  Gabriel N Mannis; Julia E Fehniger; Jennifer S Creasman; Vanessa L Jacoby; Mary S Beattie
Journal:  JAMA Intern Med       Date:  2013-01-28       Impact factor: 21.873

7.  Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.

Authors:  Sue V Petzel; Rachel Isaksson Vogel; Tracy Bensend; Anna Leininger; Peter A Argenta; Melissa A Geller
Journal:  J Genet Couns       Date:  2013-05-16       Impact factor: 2.537

8.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

Authors:  Kimberly A Lowe; Chirag Shah; Erin Wallace; Garnet Anderson; Pamela Paley; Martin McIntosh; M Robyn Andersen; Nathalie Scholler; Lindsay Bergan; Jason Thorpe; Nicole Urban; Charles W Drescher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

9.  Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families.

Authors:  Tadeusz Dębniak; Tomasz Gromowski; Rodney J Scott; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Grzegorz Kurzawski; Dagmara Dymerska; Bohdan Górski; Katarzyna Paszkowska-Szczur; Cezary Cybulski; Pablo Serrano-Fernandez; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2015-01-16       Impact factor: 2.857

10.  Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics.

Authors:  Claire Julian-Reynier; Anne-Déborah Bouhnik; Emanuelle Mouret-Fourme; Marion Gauthier-Villars; Pascaline Berthet; Christine Lasset; Jean-Pierre Fricker; Olivier Caron; Paul Gesta; Elisabeth Luporsi; Laurence Faivre; Michel Longy; Laurence Gladieff; Marc Frenay; Héléne Dreyfus; Hagay Sobol; Philippe Vennin; Catherine Nogués
Journal:  Genet Med       Date:  2010-12       Impact factor: 8.822

View more
  4 in total

1.  Competing Risks for a Diagnosis of Invasive Breast Cancer-Reply.

Authors:  Adam R Brentnall; Diana S M Buist; Jack Cuzick
Journal:  JAMA Oncol       Date:  2019-01-01       Impact factor: 31.777

Review 2.  Initiatives to Scale Up and Expand Reach of Cancer Genomic Services Outside of Specialty Clinical Settings: A Systematic Review.

Authors:  Yue Guan; Colleen M McBride; Hannah Rogers; Jingsong Zhao; Caitlin G Allen; Cam Escoffery
Journal:  Am J Prev Med       Date:  2020-11-07       Impact factor: 5.043

3.  Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.

Authors:  Banu K Arun; Susan K Peterson; Lilian E Sweeney; Rachel D Bluebond; Rebecca S S Tidwell; Sukh Makhnoon; Anne C Kushwaha
Journal:  Cancer       Date:  2021-08-23       Impact factor: 6.860

4.  Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.

Authors:  Jihyoun Jeon; Mengmeng Du; Robert E Schoen; Michael Hoffmeister; Polly A Newcomb; Sonja I Berndt; Bette Caan; Peter T Campbell; Andrew T Chan; Jenny Chang-Claude; Graham G Giles; Jian Gong; Tabitha A Harrison; Jeroen R Huyghe; Eric J Jacobs; Li Li; Yi Lin; Loïc Le Marchand; John D Potter; Conghui Qu; Stephanie A Bien; Niha Zubair; Robert J Macinnis; Daniel D Buchanan; John L Hopper; Yin Cao; Reiko Nishihara; Gad Rennert; Martha L Slattery; Duncan C Thomas; Michael O Woods; Ross L Prentice; Stephen B Gruber; Yingye Zheng; Hermann Brenner; Richard B Hayes; Emily White; Ulrike Peters; Li Hsu
Journal:  Gastroenterology       Date:  2018-02-17       Impact factor: 33.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.